Geriatric Healthcare Specialist Bristol CT

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Bryan Vincent Boffi, MD
(203) 797-7547
440 N Main St
Bristol, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Brown Univ Program In Med, Providence Ri 02912
Graduation Year: 1982

Data Provided by:
Pamela Taxel, MD
(860) 679-4743
263 Farmington Ave
Farmington, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1989

Data Provided by:
Gail Marie Sullivan, MD
(860) 679-3956
263 Farmington U Conn Health Ctr,
Farmington, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1977

Data Provided by:
Frederick North Rowland, MD
(860) 714-4749
23 Whispering Rod Rd
Unionville, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Ct Sch Of Med, Farmington Ct 06032
Graduation Year: 1987

Data Provided by:
Anne M Kenny
(860) 679-8400
263 Farmington Ave
Farmington, CT
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Patrick Pacelli Coll, MD
(860) 679-3959
263 Farmington Ave
Farmington, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Dublin, Trinity Coll, Sch Of Physic, Dublin, Ireland
Graduation Year: 1981

Data Provided by:
Naghmeh Pooya, MD
(610) 434-8801
263 Farmington Ave
Farmington, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Shahid Beheshti Univ, Fac Med, Teheran, Iran
Graduation Year: 1992

Data Provided by:
Carol Coke Pilbeam, MD
(860) 679-2129
263 Farmington Avenue Dowling South B2,
Farmington, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1982

Data Provided by:
Janet E McElhaney, MD
(860) 679-4444
263 Farmington Ave # MC-1601
Farmington, CT
Specialties
Internal Medicine, Geriatrics
Gender
Male
Education
Medical School: Univ Of Alberta, Fac Of Med, Edmonton, A
Graduation Year: 1986

Data Provided by:
Patrick Coll
(860) 679-8400
263 Farmington Ave
Farmington, CT
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...

Click here to read more from Natural Solutions